The Valley Desk

Clinical trial reportActa haematologicaPublished

Anexelekto (Axl)/Mer Inhibitor Tamnorzatinib in Patients with Relapsed/Refractory Acute Myeloid Leukaemia: Results from a Phase I (Monotherapy) and Phase II (Combination with Venetoclax) Clinical Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Acta haematologica
Published
Subject terms
Humans; Recurrence; Sulfonamides; Proto-Oncogene Proteins; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Adult; Aged; Middle Aged; Female; Male; Leukemia, Myeloid, Acute
PubMed ID
41385448
PubMed Central ID
PMC12795523
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal